A clinical update and global economic burden of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a predominant inflammatory autoimmune disorder. The incidence and prevalence of RA is increasing with considerable morbidity and mortality worldwide. The pathophysiology of RA has become clearer due to many significant research outputs during the last two decades. Many i...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Indexed Article |
| Published: |
Bentham Science Publishers
2018
|
| Online Access: | http://discol.umk.edu.my/id/eprint/7407/ https://www.ncbi.nlm.nih.gov/pubmed/29141572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Rheumatoid arthritis (RA) is a predominant inflammatory autoimmune disorder. The incidence and prevalence of RA is increasing with considerable morbidity and mortality worldwide. The pathophysiology of RA has become clearer due to many significant research outputs during the last two decades. Many inflammatory cytokines involved in RA pathophysiology and the presence of autoantibodies are being used as potential biomarkers via the use of effective diagnostic techniques for the early diagnosis of RA. Currently, several disease-modifying anti-rheumatic
drugs are being prescribed targeting RA pathophysiology, which have shown significant contributions
in improving the disease outcomes. |
|---|